Tag: Aki

Drug-induced Acute Kidney Injury (DI-AKI) accounts for a significant portion of kidney injuries in hospitalized patients, with some reports suggesting up to 37% of cases. Understanding precisely **what drugs should be avoided in AKI patients** is a critical step in managing the condition and preventing further renal damage.

The incidence of vancomycin-induced nephrotoxicity occurs in about 10% of patients receiving the drug at standard doses [1.2.1]. While a powerful antibiotic against MRSA, the question of **can vancomycin be nephrotoxic?** is a critical consideration in clinical practice.

According to studies, vancomycin-induced nephrotoxicity is generally reversible in most cases, especially with prompt discontinuation of the medication. For patients experiencing vancomycin-induced acute kidney injury (AKI), a swift and strategic medical response can mitigate damage and promote recovery.